Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Accelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity
Maria Mitry, Dimitri Laurent, Britny L. Keith, et al.
AJP Cell Physiology (2020) Vol. 318, Iss. 2, pp. C380-C391
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 659-659
Open Access | Times Cited: 301
Senescence mechanisms and targets in the heart
Maggie Chen, Richard Lee, Jessica C. Garbern
Cardiovascular Research (2021) Vol. 118, Iss. 5, pp. 1173-1187
Open Access | Times Cited: 170
Cardiomyocyte Senescence and Cellular Communications Within Myocardial Microenvironments
Xiaoqiang Tang, Peiheng Li, Hou‐Zao Chen
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 157
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases
Masayoshi Suda, Karl H. Paul, Tohru Minamino, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1296-1296
Open Access | Times Cited: 49
Cellular Senescence, Mitochondrial Dysfunction, and Their Link to Cardiovascular Disease
María Camacho Encina, Laura Booth, Rachael Redgrave, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 353-353
Open Access | Times Cited: 18
Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls
W. Andrew Owens, Anna Walaszczyk, Ioakim Spyridopoulos, et al.
Mechanisms of Ageing and Development (2021) Vol. 198, pp. 111540-111540
Open Access | Times Cited: 82
Cellular senescence and cardiovascular diseases: moving to the “heart” of the problem
Konstantinos Evangelou, Panagiotis Vasileiou, Angelos Papaspyropoulos, et al.
Physiological Reviews (2022) Vol. 103, Iss. 1, pp. 609-647
Open Access | Times Cited: 56
Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice
Araceli Lérida‐Viso, Alejandra Estepa‐Fernández, Ángela Morellá‐Aucejo, et al.
Pharmacological Research (2022) Vol. 183, pp. 106356-106356
Open Access | Times Cited: 53
Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction
Rachael Redgrave, Emily Dookun, Laura Booth, et al.
npj Aging (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 28
Artesunate ameliorates irinotecan-induced intestinal injury by suppressing cellular senescence and significantly enhances anti-tumor activity
Hui Jie Jia, Shi-rui Bai, Jing Xia, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110205-110205
Closed Access | Times Cited: 26
Priorities in Cardio-Oncology Basic and Translational Science
Fadi N. Salloum, Carlo G. Tocchetti, Pietro Ameri, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 6, pp. 715-731
Open Access | Times Cited: 23
Exosomal miR-9-5p derived from iPSC-MSCs ameliorates doxorubicin-induced cardiomyopathy by inhibiting cardiomyocyte senescence
Huifeng Zheng, Xiaoting Liang, Baojuan Liu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Morphology-based deep learning enables accurate detection of senescence in mesenchymal stem cell cultures
Liangge He, Mingzhu Li, Xinglie Wang, et al.
BMC Biology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Cardiomyocyte senescence and the potential therapeutic role of senolytics in the heart
Peiyong Zhai, Junichi Sadoshima
The Journal of Cardiovascular Aging (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 9
Cannabidiol Ameliorates Doxorubicin-Induced Myocardial Injury via Activating Hippo Pathway
Tianwei Dong, Jinlian Li, Xinfang Liang, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 569-583
Open Access | Times Cited: 1
Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization
Solomon Habtemariam
Molecules (2020) Vol. 25, Iss. 6, pp. 1426-1426
Open Access | Times Cited: 53
Therapeutic opportunities for senolysis in cardiovascular disease
Mark Sweeney, Stuart A. Cook, Jesús Gil
FEBS Journal (2022) Vol. 290, Iss. 5, pp. 1235-1255
Open Access | Times Cited: 33
Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation
Khavinson VKh, N. S. Linkova, Anastasiia Dyatlova, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 106-106
Open Access | Times Cited: 30
Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity
Aleksandra Sobiborowicz, Katarzyna Kamińska, Agnieszka Cudnoch‐Jędrzejewska
Cancers (2023) Vol. 15, Iss. 1, pp. 312-312
Open Access | Times Cited: 17
Statins for Attenuating Cardiotoxicity in Patients Receiving Anthracyclines: A Systematic Review and Meta-Analysis
Anoop Titus, Huzaifa Ahmad Cheema, Arman Shafiee, et al.
Current Problems in Cardiology (2023) Vol. 48, Iss. 10, pp. 101885-101885
Closed Access | Times Cited: 17
Cellular Senescence, Mitochondrial Dysfunction, and Their Link to Cardiovascular Disease
M. Camacho-Encina, Laura Booth, Rachael Redgrave, et al.
(2024)
Open Access | Times Cited: 6
The role of cardiomyocyte senescence in cardiovascular diseases: a molecular biology update
Shuang-Yi He, Yan Li, Chao Yuan, et al.
European Journal of Pharmacology (2024) Vol. 983, pp. 176961-176961
Closed Access | Times Cited: 6
Light-Responsive Micelles Loaded With Doxorubicin for Osteosarcoma Suppression
Jiayi Chen, Chenhong Qian, Peng Ren, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 35
Nutritional components as mitigators of cellular senescence in organismal aging: a comprehensive review
Bhawna Diwan, Rohit Sharma
Food Science and Biotechnology (2022) Vol. 31, Iss. 9, pp. 1089-1109
Open Access | Times Cited: 26
Quercetin and dasatinib, two powerful senolytics in age-related cardiovascular disease
Mario Nieto, Mina Konigsberg, Alejandro Silva‐Palacios
Biogerontology (2023) Vol. 25, Iss. 1, pp. 71-82
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top